Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.
about
A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women.Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphismsRelationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publicationsGenotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate CancerGenetic variation: effect on prostate cancer.Hormones and prostate cancer: current perspectives and future directions.Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.Pharmacogenetics of human androgens and prostate cancer--an update.Genomic biomarkers, androgen pathway and prostate cancer.Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.Association between hormonal genetic polymorphisms and early-onset prostate cancer.The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
P2860
Q24796415-23821285-1F75-4927-80CD-7D59D148D9F6Q28245628-767B579F-9340-4DC5-BE01-4EBA626F4FD4Q33672581-BBFB62D8-62C6-4A56-B514-E2DC486743F3Q33823048-8ACC22E0-A451-4D8E-8254-F272991B8086Q34663656-2BC53756-6111-4B4A-85F0-75C72EBD11AAQ34732880-4E3542AA-9315-46B1-9EA4-F181C57AB112Q35117241-96790A96-2EF3-475B-808B-1024B20B4D02Q35753329-9146EF5B-CDC6-4BD3-81F2-E38D53380853Q36845131-90BA28ED-CBF0-4AE2-B13A-EFB7206AFC24Q37151872-0DF421F0-4743-4719-AFAF-592C4C31598DQ37294754-65227D06-CCFD-44AD-9F7D-71C4B86ADF39Q37633264-A29F4AE6-B534-424E-9EF9-D529B01568D5Q43275499-B741ACE7-18E7-493F-86AB-46E0964C98A7Q43595675-774433C5-0694-4844-AD3F-38BDD5AFB930Q44124762-A113A71F-F1FF-41CF-9716-6BF6EB110888Q45265466-019F4B7E-8DA1-488A-91BD-E862F8DD0032Q46379814-364F0DC5-F9EC-4978-A382-399A93A747E3
P2860
Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Evidence for an association be ...... te cancer in Italian patients.
@en
Evidence for an association between the SRD5A2
@nl
type
label
Evidence for an association be ...... te cancer in Italian patients.
@en
Evidence for an association between the SRD5A2
@nl
prefLabel
Evidence for an association be ...... te cancer in Italian patients.
@en
Evidence for an association between the SRD5A2
@nl
P2093
P356
P1433
P1476
Evidence for an association be ...... ate cancer in Italian patients
@en
P2093
B Dallapiccola
C Franceschi
C L Pearce
F Sangiuolo
K Margiotti
P304
P356
10.1155/2000/683607
P577
2000-01-01T00:00:00Z